P. Mildred and T. Stahlman, , 1982.

P. Théodore and H. Schiebler, , 1989.

P. Mashaki and K. , , 1996.

P. Maria and D. , , 1996.

P. Ralph and G. , , 1996.

P. Duong-quang and T. , , 1997.

P. Marc and L. , , 2005.

P. Brian and B. , , 2007.

P. Yunfeng and Z. , , 2009.

P. David and A. , , 2011.

W. Whiteley, Y. Tian, and G. C. Jickling, Blood biomarkers in stroke: research and clinical practice, Int J Stroke, vol.7, pp.435-439, 2012.

W. Whiteley, W. L. Chong, and A. Sengupta, Blood markers for the prognosis of ischemic stroke: a systematic review, Stroke, vol.40, pp.380-389, 2009.

N. Turck, X. Robin, and N. Walter, Blood glutathione S-transferase-? as a time indicator of stroke onset, PLoS One, vol.7, p.43830, 2012.

G. Thomalla, B. Cheng, and M. Ebinger, DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study, Lancet Neurol, vol.10, pp.978-986, 2011.

E. C. Jauch, J. L. Saver, and A. Hp, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, vol.44, pp.870-947, 2013.

L. Dayon, N. Turck, and T. Garcí-berrocoso, Brain extracellular fluid protein changes in acute stroke patients, J Proteome Res, vol.10, pp.1043-1051, 2011.

A. Wouters, R. Lemmens, and P. Dupont, Wake-up stroke and stroke of unknown onset : a critical review, Front Neurol, vol.5, p.153, 2014.

P. A. Barber, J. Zhang, and A. M. Demchuk, Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility, Neurology, vol.56, pp.1015-1020, 2001.

R. A. Poynton and M. B. Hampton, Peroxiredoxins as biomarkers of oxidative stress, Biochim Biophys Acta, vol.1840, pp.906-912, 2014.

H. Sies, V. S. Sharov, and L. O. Klotz, Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase, J Biol Chem, vol.272, pp.27812-27817, 1997.

C. Michiels, M. Raes, and O. Toussaint, Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress

, Free Radic Biol Med, vol.17, pp.235-248, 1994.

J. N. Keller, F. F. Huang, and H. Zhu, Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury, J Cereb Blood Flow Metab, vol.20, pp.1467-1473, 2000.

L. Zhang, S. Huang, and Y. Chen, Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin, Basic Clin Pharmacol Toxicol, vol.107, pp.899-905, 2010.

R. C. Strange, M. A. Spiteri, and S. Ramachandran, Glutathione-S-transferase family of enzymes, Mutat Res, vol.482, pp.21-26, 2001.

K. D. Tew and D. M. Townsend, Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification, Drug Metab Rev, vol.43, pp.179-193, 2011.

S. Sun, H. Zhang, and B. Xue, Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats, Inflamm Res, vol.55, pp.504-510, 2006.

L. Luo, Y. Wang, and Q. Feng, Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice, Mol Immunol, vol.46, pp.848-857, 2009.

C. A. Neumann, J. Cao, and Y. Manevich, Peroxiredoxin 1 and its role in cell signaling, Cell Cycle, vol.8, pp.4072-4078, 2009.

R. R. Tao, H. Wang, and L. J. Hong, Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo, Antioxid Redox Signal, vol.21, pp.1-16, 2014.

R. K. Leak, L. Zhang, and Y. Luo, Peroxiredoxin, vol.2

, polymerase 1-and p53-dependent prodeath pathways after ischemic injury, Stroke, vol.44, pp.1124-1134, 2013.

G. Schreibelt, J. Van-horssen, and R. F. Haseloff, Protective effects of peroxiredoxin-1 at the injured blood-brain barrier, Free Radic Biol Med, vol.45, pp.256-264, 2008.

L. Garcia-bonilla and C. Iadecola, Peroxiredoxin sets the brain on fire after stroke, Nat Med, vol.18, pp.858-859, 2012.

T. Shichita, E. Hasegawa, and A. Kimura, Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain, Nat Med, vol.18, pp.911-917, 2012.

S. V. Kabadi, B. A. Stoica, and D. B. Zimmer, S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury, J Cereb Blood Flow Metab, vol.35, pp.2010-2020, 2015.

S. Richard, L. Lagerstedt, and P. R. Burkhard, E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases, J Inflamm (Lond), vol.12, p.61, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01812488

L. He, T. Nan, and Y. Cui, Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin, Malar J, vol.13, p.127, 2014.

T. Partie,

A. Wouters, R. Lemmens, and P. Dupont, Wake-up stroke and stroke of unknown onset : a critical review, Front Neurol, vol.5, p.153, 2014.

P. A. Barber, J. Zhang, and A. M. Demchuk, Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility, Neurology, vol.56, pp.1015-1020, 2001.

, Tissue plasminogen activator for acute ischemic stroke. The National Institute of

, Neurological Disorders and Stroke rt-PA Stroke Study Group (NINDS), N Engl J Med, vol.333, pp.1581-1588, 1995.

W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Dávalos et al., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke, N Engl J Med, vol.359, pp.1317-1346, 2008.

O. A. Berkhemer, P. S. Fransen, D. Beumer, L. A. Van-den-berg, H. F. Lingsma et al., A randomized trial of intraarterial treatment for acute ischemic stroke, N Engl J Med, vol.372, pp.11-20, 2015.

B. C. Campbell, P. J. Mitchell, T. J. Kleinig, H. M. Dewey, L. Churilov et al.,

, Endovascular therapy for ischemic stroke with perfusion-imaging selection, N Engl J Med, vol.372, pp.1009-1027, 2015.

K. R. Lees, E. Bluhmki, V. Kummer, R. Brott, T. G. Toni et al., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, Lancet, vol.375, pp.1695-703, 2010.

G. Thomalla, B. Cheng, and M. Ebinger, DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicenter observational study, Lancet Neurol, vol.10, pp.978-86, 2011.

E. C. Jauch, J. L. Saver, and A. Hp, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the

, American Heart Association/American Stroke Association. Stroke, vol.44, pp.870-947, 2013.

L. Dayon, N. Turck, and T. Garcí-berrocoso, Brain extracellular fluid protein changes in acute stroke patients, J Proteome Res, vol.10, pp.1043-1051, 2011.

N. Turck, X. Robin, and N. Walter, Blood glutathione S-transferase-? as a time indicator of stroke onset, PLoS One, vol.7, p.43830, 2012.

R. A. Poynton and M. B. Hampton, Peroxiredoxins as biomarkers of oxidative stress

, Biochim Biophys Acta, vol.1840, pp.906-912, 2014.

H. Sies, V. S. Sharov, and L. O. Klotz, Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase, J Biol Chem, vol.272, pp.27812-27817, 1997.

C. Michiels, M. Raes, and O. Toussaint, Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress, Free Radic Biol Med, vol.17, pp.235-248, 1994.

J. N. Keller, F. F. Huang, and H. Zhu, Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury, J Cereb Blood Flow Metab, vol.20, pp.1467-1473, 2000.

R. R. Tao, H. Wang, and L. J. Hong, Nitrosative stress induces peroxiredoxin 1

, ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo, Antioxid Redox Signal, vol.21, pp.1-16, 2014.

R. C. Strange, M. A. Spiteri, and S. Ramachandran, Glutathione-S-transferase family of enzymes, Mutat Res, vol.482, pp.21-26, 2001.

K. D. Tew and D. M. Townsend, Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification, Drug Metab Rev, vol.43, pp.179-193, 2011.

S. Sun, H. Zhang, and B. Xue, Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats, Inflamm Res, vol.55, pp.504-510, 2006.

L. Luo, Y. Wang, and Q. Feng, Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice, Mol Immunol, vol.46, pp.848-857, 2009.

R. K. Leak, L. Zhang, and Y. Luo, Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1and p53-dependent prodeath pathways after ischemic injury, Stroke, vol.44, pp.1124-1134, 2013.

G. Schreibelt, J. Van-horssen, and R. F. Haseloff, Protective effects of peroxiredoxin-1 at the injured blood-brain barrier, Free Radic Biol Med, vol.45, pp.256-264, 2008.

L. Garcia-bonilla and C. Iadecola, Peroxiredoxin sets the brain on fire after stroke, Nat Med, vol.18, pp.858-859, 2012.

T. Shichita, E. Hasegawa, and A. Kimura, Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain, Nat Med, vol.18, pp.911-917, 2012.

G. Thomalla, J. B. Fiebach, and L. Østergaard, A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP), Int J Stroke, vol.9, pp.829-865, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02045531

W. Whiteley, Y. Tian, and G. C. Jickling, Blood biomarkers in stroke: research and clinical practice, Int J Stroke, vol.7, pp.435-439, 2012.

W. Whiteley, W. L. Chong, and A. Sengupta, Blood markers for the prognosis of ischemic stroke: a systematic review, Stroke, vol.40, pp.380-389, 2009.

H. Autorité-de-santé, Accident vasculaire cérébral : prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, 2009.

M. G. Bousser, P. Amarenco, A. Chamorro, M. Fisher, I. Ford et al., Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, doubleblind, parallel-group trial, Lancet, vol.377, pp.2013-2035, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00771537

R. L. Sacco, H. C. Diener, and S. Yusuf, Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke, N Engl J Med, vol.359, pp.1238-51, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00627279